Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Monopar Therapeutics Inc (MNPR)
NASDAQ:MNPR
Monopar Therapeutics Inc (MNPR) Stock Price & Analysis
266 Followers
MNPR Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.81 - $4.88
Previous Close$0.92
Volume1.40K
Average Volume (3M)30.74K
Market Cap
$12.43M
Enterprise Value$6.40M
Total Cash (Recent Filing)$5.73M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)-1.1
Beta-0.30
Next Earnings
Aug 10, 2023EPS Estimate
-$0.19Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.82
Shares Outstanding10,736,396
10 Day Avg. Volume12,532
30 Day Avg. Volume30,739
Standard Deviation0.21
R-Squared0.08
Alpha-0.05
Financial Highlights & Ratios
Price to Book (P/B)1.30
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-1.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-0.60
Forecast
1Y Price Target
$6.88Price Target Upside631.91% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
Monopar Therapeutics Inc News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
MNPR FAQ
What was Monopar Therapeutics Inc’s price range in the past 12 months?
Monopar Therapeutics Inc lowest stock price was $0.81 and its highest was $4.88 in the past 12 months.
What is Monopar Therapeutics Inc’s market cap?
Currently, no data Available
When is Monopar Therapeutics Inc’s upcoming earnings report date?
Monopar Therapeutics Inc’s upcoming earnings report date is Aug 10, 2023 which is in 72 days.
How were Monopar Therapeutics Inc’s earnings last quarter?
Monopar Therapeutics Inc released its earnings results on May 11, 2023. The company reported -$0.19 earnings per share for the quarter, beating the consensus estimate of -$0.222 by $0.032.
Is Monopar Therapeutics Inc overvalued?
According to Wall Street analysts Monopar Therapeutics Inc’s price is currently Undervalued.
Does Monopar Therapeutics Inc pay dividends?
Monopar Therapeutics Inc does not currently pay dividends.
What is Monopar Therapeutics Inc’s EPS estimate?
Monopar Therapeutics Inc’s EPS estimate is -$0.19.
How many shares outstanding does Monopar Therapeutics Inc have?
Monopar Therapeutics Inc has 13,222,056 shares outstanding.
What happened to Monopar Therapeutics Inc’s price movement after its last earnings report?
Monopar Therapeutics Inc reported an EPS of -$0.19 in its last earnings report, beating expectations of -$0.222. Following the earnings report the stock price went down -7%.
Which hedge fund is a major shareholder of Monopar Therapeutics Inc?
Currently, no hedge funds are holding shares in MNPR
---
Monopar Therapeutics Inc Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$6.88 (631.91% Upside)
$6.88 (631.91% Upside)
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-59.24%
12-Months-Change
Fundamentals
Return on Equity
-80.99%
Trailing 12-Months
Asset Growth
-34.51%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Monopar Therapeutics Inc
Monopar Therapeutics, Inc. engages in developing orphan oncology drugs. The company was founded by Chandler D. Robinson, Christopher M. Starr and Andrew P. Mazar in December 2014 and is headquartered in Wilmette, IL.
---
Top 5 ETFs holding MNPR
Currently, no data available
Please return soon. This page is being updated.
Up to five ETFs with an Outperform Smart Score that hold MNPR. The ETFs are listed according to market value of MNPR within the ETF
---
Acurx Pharmaceuticals
―
Eledon Pharmaceuticals
―
TRACON Pharmaceuticals
―
BioCardia
―
Applied Molecular Transport
―
---